Biogen Idec Clears The Air: No Large Companies Meet Dual Test For Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Putting a “permanent for sale sign out on the front lawn” is not the appropriate way to run the biotech either, CEO Mullen maintains.